System C Healthcare plc
01 August 2007
System C Healthcare PLC
Board Changes
System C Healthcare plc ("System C") announces that Jim Horsburgh has decided to
relinquish his role as Executive Chairman, but the Board is pleased to confirm
that he has agreed to remain as a Non-Executive Chairman. This change will take
effect from 1st September 2007 and allows Jim more flexibility to develop his
other business opportunities. John Forrest will remain as Senior Independent
Director and will also become Deputy Non-Executive Chairman, also with effect
from 1 September 2007.
This will leave the Board with a good balance of four non-executive directors
and three executive directors to take System C forwards.
Jim Horsburgh commented "After 7 years with System C I am delighted that it has
progressed to the point where I am able to relinquish my executive role
confident in the knowledge that the team led by Ian Denley has all the qualities
to take the company through its next stage of growth. I look forward to my role
as Non-Executive Chairman and also to continued further progress at System C."
The Board also confirms that, as reported in the trading update on 23 May,
trading has continued to be encouraging. It is expected that System C will
report its preliminary results for the year ended 31 May 2007 on Wednesday,
12 September.
ENDS
For further information, please contact:
System C Healthcare plc Jim Horsburgh, Chairman Tel: 01622 691616
Dr Ian Denley, Chief Executive
Maitland Emma Burdett Tel: 020 7379 5151
Richard Farnsworth
Collins Stewart Europe Ltd Chris Wells Tel: 020 7523 8350
Mark Connelly
Notes to editors:
System C Healthcare plc (www.systemc.com), established in 1983, specialises in
the provision of information systems and solutions to the healthcare sector. Its
staff have an average of 15 years' healthcare experience and can provide all
aspects of systems design, development and deployment services. System C is
founded upon the belief that IT solutions, when effectively implemented, can
significantly contribute towards improving patient care.
System C is a specialist developer and supplier of Patient Administration and
Electronic Patient Record Systems to the health service. The company's MedWay
product is successfully installed at a number of NHS hospitals including
University Hospitals Aintree, Swindon and Marlborough NHS Trust, Tameside
Hospitals NHS Trust and the Christie, one of the UK's leading cancer hospitals.
System C has recently won a £7.5m contract to supply MedWay to the Isle of Man
Government.
System C has helped to install healthcare systems at over 130 NHS Trusts and
offers a wide range of services to Local Service Providers, the NHS and
third-party suppliers. These include programme/project/change management,
design, build and test, implementation, training, data migration, interfacing
and helpdesk/support services. Within the National Programme for IT (NPfIT),
System C people have been involved in the majority of secondary care go-lives to
date as well as many GP, community, Single Assessment Programme and child health
deployments.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.